Neonatal extrapyramidal movements. Neonatal withdrawal due to maternal citalopram and ondansetron use

Pediatr Ann. 2008 Mar;37(3):128-30. doi: 10.3928/00904481-20080301-01.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Anxiety Agents / adverse effects*
  • Basal Ganglia Diseases / chemically induced
  • Basal Ganglia Diseases / diagnosis*
  • Basal Ganglia Diseases / drug therapy
  • Citalopram / adverse effects*
  • Female
  • Humans
  • Infant, Newborn
  • Lorazepam / therapeutic use
  • Maternal Welfare*
  • Ondansetron / adverse effects*
  • Phenobarbital / therapeutic use
  • Pregnancy
  • Prenatal Exposure Delayed Effects / chemically induced
  • Prenatal Exposure Delayed Effects / diagnosis*
  • Prenatal Exposure Delayed Effects / drug therapy
  • Selective Serotonin Reuptake Inhibitors / adverse effects*
  • Substance Withdrawal Syndrome / etiology*

Substances

  • Anti-Anxiety Agents
  • Serotonin Uptake Inhibitors
  • Citalopram
  • Ondansetron
  • Lorazepam
  • Phenobarbital